Ryan Specialty (NYSE:RYAN) Price Target Raised to $48.00

Ryan Specialty (NYSE:RYAN) had its target price raised by Keefe, Bruyette & Woods from $44.00 to $48.00 in a research report sent to investors on Wednesday,Benzinga reports. Keefe, Bruyette & Woods currently has an outperform rating on the stock.

Other analysts have also issued reports about the company. Piper Sandler dropped their target price on Ryan Specialty from $43.00 to $35.00 and set a “neutral” rating on the stock in a report on Friday, May 1st. Morgan Stanley lifted their price target on Ryan Specialty from $39.00 to $42.00 and gave the company an “overweight” rating in a research report on Monday. Barclays boosted their price target on Ryan Specialty from $39.00 to $46.00 and gave the company an “overweight” rating in a report on Tuesday. Cantor Fitzgerald dropped their price objective on shares of Ryan Specialty from $45.00 to $40.00 and set a “neutral” rating on the stock in a research note on Thursday, April 9th. Finally, Zacks Research raised shares of Ryan Specialty from a “strong sell” rating to a “hold” rating in a research note on Tuesday, June 30th. Eight investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $48.59.

Ryan Specialty Trading Down 0.5%

NYSE RYAN opened at $40.40 on Wednesday. Ryan Specialty has a 1 year low of $29.28 and a 1 year high of $67.69. The company has a debt-to-equity ratio of 2.90, a current ratio of 1.02 and a quick ratio of 1.02. The company has a market capitalization of $10.65 billion, a PE ratio of 52.46, a P/E/G ratio of 0.98 and a beta of 0.61. The company has a fifty day moving average of $34.64 and a 200 day moving average of $39.40.

Ryan Specialty (NYSE:RYAN) last announced its quarterly earnings results on Thursday, April 30th. The company reported $0.47 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.04. The company had revenue of $795.23 million for the quarter, compared to the consensus estimate of $781.44 million. Ryan Specialty had a return on equity of 41.33% and a net margin of 8.21%.The firm’s revenue for the quarter was up 15.2% compared to the same quarter last year. During the same period last year, the firm earned $0.39 EPS. Research analysts forecast that Ryan Specialty will post 2.05 earnings per share for the current year.

Ryan Specialty Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, May 26th. Investors of record on Tuesday, May 12th were issued a $0.13 dividend. The ex-dividend date of this dividend was Tuesday, May 12th. This represents a $0.52 dividend on an annualized basis and a yield of 1.3%. Ryan Specialty’s dividend payout ratio is presently 67.53%.

Ryan Specialty declared that its board has authorized a share repurchase program on Tuesday, May 26th that allows the company to repurchase $300.00 million in shares. This repurchase authorization allows the company to reacquire up to 3.5% of its shares through open market purchases. Shares repurchase programs are often a sign that the company’s management believes its stock is undervalued.

Insiders Place Their Bets

In other Ryan Specialty news, Director John W. Rogers, Jr. acquired 7,500 shares of the business’s stock in a transaction dated Wednesday, June 10th. The stock was acquired at an average cost of $35.16 per share, for a total transaction of $263,700.00. Following the completion of the transaction, the director directly owned 117,933 shares of the company’s stock, valued at $4,146,524.28. This represents a 6.79% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Mark Stephen Katz bought 3,215 shares of Ryan Specialty stock in a transaction dated Wednesday, June 3rd. The shares were acquired at an average cost of $31.07 per share, with a total value of $99,890.05. Following the completion of the purchase, the executive vice president owned 4,332 shares in the company, valued at approximately $134,595.24. This trade represents a 287.82% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last 90 days, insiders have acquired 130,715 shares of company stock worth $4,263,590. 52.03% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Ryan Specialty

Institutional investors have recently added to or reduced their stakes in the stock. Beck Mack & Oliver LLC acquired a new position in shares of Ryan Specialty during the 3rd quarter worth about $2,818,000. Geneva Capital Management LLC boosted its holdings in Ryan Specialty by 11.2% in the 3rd quarter. Geneva Capital Management LLC now owns 535,742 shares of the company’s stock worth $30,194,000 after buying an additional 53,810 shares during the last quarter. Westview Management dba Westview Investment Advisors acquired a new stake in Ryan Specialty in the 4th quarter worth about $2,082,000. SG Americas Securities LLC purchased a new stake in Ryan Specialty during the 4th quarter worth approximately $20,776,000. Finally, Stephens Investment Management Group LLC increased its stake in Ryan Specialty by 41.6% during the 4th quarter. Stephens Investment Management Group LLC now owns 1,929,094 shares of the company’s stock worth $99,599,000 after buying an additional 566,610 shares in the last quarter. Institutional investors and hedge funds own 84.82% of the company’s stock.

Trending Headlines about Ryan Specialty

Here are the key news stories impacting Ryan Specialty this week:

• Neutral Sentiment: Wells Fargo raised its price target on Ryan Specialty to $39 from $31 and kept an equal-weight rating, signaling more confidence in the business but not a bullish call. Ryan Specialty (NYSE:RYAN) Price Target Raised to $39.00 at Wells Fargo & Company
• Neutral Sentiment: Mizuho also lifted its price target to $39 from $35 while maintaining a neutral rating, which supports valuation but does not point to significant upside from here. Ryan Specialty (NYSE:RYAN) Given New $39.00 Price Target at Mizuho
• Negative Sentiment: Wolfe Research downgraded Ryan Specialty to Peer Perform from Outperform, a move that can weigh on sentiment by suggesting the stock’s recent run may have already priced in much of the good news. Ryan Specialty (NYSE:RYAN) Downgraded by Wolfe Research to “Peer Perform”
• Neutral Sentiment: Separately, a market commentary piece noted Ryan Specialty looks expensive on price but attractive on earnings quality, reinforcing a mixed investor view rather than a clear catalyst. Ryan Specialty (RYAN) Stock Looks Weak On Price But Rich On Earnings

Ryan Specialty Company Profile

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.